| | | 13260 | | 25.01.1949 | | Sanofi SA/Sanofi AG | | | | | | | | | | | | | | | 30.11.2004 | | | | |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Nasobol | comprimés | Tablets (Benzoic Acid 52 mg, Eucalypti Aetheroleum 10 mg, Lavandulae Aetheroleum 6 mg, Serpylli Aetheroleum 6 mg, Verbenae Aetheroleum 15 mg, Balsamum Peruvianum 10 mg) | R05X | CI |
|
|
